• Mashup Score: 1

    Join Team Stop the Clot® and celebrate World Thrombosis Day by participating in a 10k, 5k, or 1-mile Fun Run/Walk between October 13 – 16.

    Tweet Tweets with this article
    • Let's get moving this Sunday morning! Run or walk a 10K, 5K, or a 1-mile course anytime before tomorrow at 11:59 p.m. ET. Be sure to tag us @stoptheclot. 🩸 Register Now: https://t.co/xLlVKVnadu #RaceToStopTheClot #StopTheClot #thrombosis #DVT #PE #VTE #bloodclotawareness https://t.co/16Xs4R9S4p

  • Mashup Score: 3

    About ScienceDirectRemote accessShopping cartAdvertiseContact and supportTerms and conditionsPrivacy policyWe use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies.All content on this site: Copyright © 2023 Elsevier B.V., its licensors, and contributors. All rights are reserved, including those for text and data mining, AI…

    Tweet Tweets with this article
    • "Alongside the latest ground-breaking research, clear communication is needed to put the patient at the centre of understanding their #thrombosis risk, diagnosis pathway, and treatment" On #WorldThrombosisDay #WTDay23 read our latest editorial https://t.co/63kcFylo65

  • Mashup Score: 7

    Join Team Stop the Clot® and celebrate World Thrombosis Day by participating in a 10k, 5k, or 1-mile Fun Run/Walk between October 13 – 16.

    Tweet Tweets with this article
    • Tomorrow is #WTDay23! Want to join the fight against #thrombosis? 🩸Participate in our virtual Fun Run, which kicks off tomorrow! https://t.co/xLlVKVnadu 🩸Join @thrombosisday #ClotChat conversation tomorrow at noon ET. 🩸Share your #stoptheclotstory with our community! https://t.co/qygexp5t8E

  • Mashup Score: 1

    In an Australian phase III trial (TARGET-TP) reported in JAMA Oncology, Alexander et al found that ambulatory thromboprophylaxis reduced the risk of thromboembolic events in patients starting systemic therapy for lung or gastrointestinal cancer who were at elevated risk of thrombosis. The multicenter trial included 328 patients initiating systemic anticancer therapy for gastrointestinal cancer (n = 201) or lung cancer (n = 127) beginning in June 2018; a total of 132 patients had metastatic disease.

    Tweet Tweets with this article
    • Ambulatory Thromboprophylaxis in Patients With Cancer https://t.co/JJiQIWwpFC #cancer #thrombosis